"The webcast DV4 produced has been a great tool to introduce TriMod to potential collaborators and investors."
Jeremy Skillington - Co founder and CEO
TriMod Therapeutics is founded on ground-breaking cancer immunotherapy technology originating from the laboratory of Prof Kingston Mills at Trinity College Dublin.
TriMod faces significant expenses in travelling to the USA on a regular basis. The webcast that DV4 produced has reduced costs by generating more leads and qualifying prospects enabling TriMod to reduce travel expenditure and downtime.
Full testimonial:
The DV4 team were excellent to work with. The webcast they produced has been a great tool to introduce TriMod to potential collaborators and investors. The feedback has been very positive and clearly a good investment on our part.
